Efficacy of ursodeoxycholic acid administration as adjuvant therapy together with alfa-interferon for chronic hepatitis C.

被引：0
|
作者：
Fabbri, C [1 ]
Mazzella, G [1 ]
Marchetto, S [1 ]
Pezzoli, A [1 ]
Fusaroli, P [1 ]
Accogli, E [1 ]
Azzaroli, F [1 ]
Mazzeo, C [1 ]
Jaboli, F [1 ]
Roda, E [1 ]
机构：
[1] UNIV BOLOGNA, DEPT INTERNAL MED & GASTROENTEROL, BOLOGNA, ITALY
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1261 / A1261
页数：1
相关论文
共 50 条
  • [21] Adjuvant tauroursodeoxycholic acid (t-UDCA) therapy for interferon (IFN) treatment of chronic hepatitis C.
    Pigozzi, MG
    Sorbara, R
    Reggiani, A
    Lorini, GP
    Viviani, G
    DeTavonatti, M
    Carbone, C
    Rotondi, A
    Bettini, L
    Lanzini, A
    HEPATOLOGY, 1996, 24 (04) : 1108 - 1108
  • [22] Serum hyaluronic acid does not predict response to interferon alfa in chronic hepatitis C.
    Roberts, S
    Gibson, P
    Cromie, S
    Jenkins, P
    Dudley, F
    HEPATOLOGY, 1997, 26 (04) : 720 - 720
  • [23] HUMAN-LEUKOCYTE ALFA-INTERFERON IN CHRONIC C-HEPATITIS - PRELIMINARY-RESULTS USING DIFFERENT SCHEDULE ADMINISTRATION
    MAZZELLA, G
    BOCCIA, S
    CASETTI, T
    GANDOLFI, L
    BRAMBATI, M
    GULLINI, S
    PRIMERANO, AM
    SALZETTA, A
    RODA, E
    HEPATOLOGY, 1993, 18 (04) : A244 - A244
  • [24] EFFICACY OF COMBINATION THERAPY OF INTERFERON WITH URSODEOXYCHOLIC ACID (UDCA) IN CHRONIC HEPATITIS-C - SUSTAINED CLEARANCE OF VIREMIA AFTER INTERFERON DISCONTINUATION
    KAWATA, S
    TAMURA, S
    INADA, M
    ITO, N
    INUI, Y
    NAGASE, N
    FUKUDA, K
    KISO, S
    YAMASAKI, E
    MAEDA, Y
    TSUSHIMA, H
    IKURA, T
    MATSUZAWA, Y
    HEPATOLOGY, 1994, 20 (04) : A363 - A363
  • [25] Interferon alfa and ursodeoxycholic acid combination versus interferon alone in the treatment of chronic hepatitis C: Results of a randomized trial.
    Bonnand, AM
    Poupon, R
    Queneau, PE
    Trepo, C
    Cohard, M
    Vetter, D
    Raabe, JJ
    Lamey, D
    Grange, JD
    Capron, JP
    Serfaty, L
    Chretien, Y
    SaintMarcGirardin, MF
    MathiexFortunet, H
    Zafrani, ES
    Poupon, RE
    HEPATOLOGY, 1996, 24 (04) : 1107 - 1107
  • [26] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [27] Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
    Kiso, S
    Kawata, S
    Tamura, S
    Imai, Y
    Inui, Y
    Nagase, T
    Maeda, Y
    Yamasaki, E
    Tsushima, H
    Igura, T
    Himeno, S
    Seki, K
    Matsuzawa, Y
    JOURNAL OF GASTROENTEROLOGY, 1997, 32 (01) : 56 - 62
  • [28] Interferon-induced retinopathy in a uniform regimen of natural interferon-alfa therapy for chronic hepatitis C.
    Saito, H
    Ebinuma, H
    Nagata, H
    Inagaki, Y
    Wakabayashi, K
    Takagi, T
    Ishii, H
    GASTROENTEROLOGY, 2000, 118 (04) : A1484 - +
  • [29] SUDDEN ONSET OF ORAL ULCERATIVE LICHEN IN A PATIENT WITH CHRONIC HEPATITIS-C ON TREATMENT WITH ALFA-INTERFERON
    PAPINI, M
    BRUNI, PL
    BETTACCHI, A
    LIBERATI, F
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1994, 33 (03) : 221 - 222
  • [30] INTERFERON-ALFA AND URSODEOXYCHOLIC ACID VS INTERFERON-ALFA ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - A RANDOMIZED, CONTROLLED, CLINICAL-TRIAL
    ANGELICO, M
    GANDIN, C
    GOFFREDO, F
    PESCARMONA, E
    DELVECCHIO, C
    CAPOCACCIA, L
    HEPATOLOGY, 1992, 16 (02) : 513 - 513
12345